Clinical trial
Chinese Registry of Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (5A) Protocol: Rationale, Design and Methodology
NCT04398992 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chinese Registry of Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (5A) Protocol: Rationale, Design and Methodology
- Lead sponsor
- Nanjing Medical University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2016
- Completion date
- December 31, 2030
- Enrollment
- 10,000 (estimated)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.